Investors Say Novo Nordisk Misled Them Over Drug Demand

By George Woolston · August 4, 2025, 4:53 PM EDT

Novo Nordisk was hit with a proposed securities class action in New Jersey federal court alleging the company misled investors over its revenue outlook for 2025 by allegedly overstating the likelihood...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login